ACTAVIS LAUNCHES TRIMIPRAMINE MALEATE CAPSULES IN THE U.S.

Actavis U.S., the United States manufacturing and marketing division of the international generic pharmaceutical company Actavis Group, announced that it has received approval from the U.S. Food & Drug Administration to market Trimipramine Maleate Capsules. Distribution of the product will commence immediately.

BioSpace (http://www.biospace.com/news_story.aspx?StoryID=30956&full=1)